menu
    • menu

    Company profile for Medolife

    NEW Drugs in Dev: 3
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medolife creates a scientific bridge between natural alternative and conventional medicine. Medolife has established the world’s first Scorpion reservation which is 50,000 square meters and can produce millions of life saving nutraceuticals and dietary supplements to meet global demand.Medolife’s management team is comprised of experts and professionals in the medical, business, sales and management fields.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MedolifeUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    433 N Camden Dr, Beverly Hills, CA 90210
    Telephone
    Telephone
    8008597036
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://medolife.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medolife Rx Schedules Conference Call with Investment Community
    Medolife Rx Schedules Conference Call with Investment Community

    04 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/04/2435635/0/en/Medolife-Rx-Schedules-Conference-Call-with-Investment-Community-to-Discuss-New-Updates-and-Answer-Questions.html

    GLOBENEWSWIRE
    04 May 2022
    Share Share
    Medolife Rx Announces Changes to Management and Improvements to AELIA
    Medolife Rx Announces Changes to Management and Improvements to AELIA

    07 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/07/2380048/0/en/Medolife-Rx-Announces-Changes-to-Management-and-Improvements-to-AELIA-s-Marketing-Efforts.html

    GLOBENEWSWIRE
    07 Feb 2022
    Share Share
    Medolife Rx Presents Its Venom-To-Drug Development Projects
    Medolife Rx Presents Its Venom-To-Drug Development Projects

    11 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/11/2364809/0/en/Medolife-Rx-Presents-Its-Venom-To-Drug-Development-Projects-at-an-International-Conference-Held-in-the-Dominican-Republic.html

    GLOBENEWSWIRE
    11 Jan 2022
    Share Share
    Medolife Rx Schedules Conference Call with Investment Community
    Medolife Rx Schedules Conference Call with Investment Community

    19 Nov 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/11/19/2338216/0/en/Medolife-Rx-Schedules-Conference-Call-with-Investment-Community-To-Discuss-Third-Quarter-2021-Financial-and-Operational-Results-and-New-Updates.html

    GLOBENEWSWIRE
    19 Nov 2021
    Share Share
    Medolife Rx Reports 257% Increase in Efficacy of Ibuprofen
    Medolife Rx Reports 257% Increase in Efficacy of Ibuprofen

    12 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/12/2312612/0/en/Medolife-Rx-Reports-257-Increase-in-Efficacy-of-Ibuprofen-Through-Proprietary-Polarization-Method-Looks-to-Expand-Into-Other-APIs.html

    GLOBENEWSWIRE
    12 Oct 2021
    Share Share
    Medolife Rx Initiates Comparative Study of Its Flagship CBD-based Muscle
    Medolife Rx Initiates Comparative Study of Its Flagship CBD-based Muscle

    06 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/06/2309562/0/en/Medolife-Rx-Initiates-Comparative-Study-of-Its-Flagship-CBD-based-Muscle-Rub-and-Competitor.html

    GLOBENEWSWIRE
    06 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search